Rigel Pharmaceuticals | Beneficio Operativo

Precio De Mercado
32.96
Cambio Diario
-1.66 -4.79%
Mensual
-5.69%
Anual
49.28%
Q1 Expectativa
33.68




Beneficio Operativo Cambio Fecha
Agenus USD -13.31M 12.58M 2025-03
Amgen USD 3.96B 464M 2025-12
Anika Therapeutics USD -4.28M 32.1M 2025-03
Arrowhead Research USD 40.81M 3.3M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Celldex Therapeutics USD -87.15M 13.54M 2025-12
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Heron Therapeutics USD -5.66M 782K 2024-09
Intrexon USD -60.84M 26.62M 2024-06
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Karyopharm Therapeutics USD -31.28M 5M 2024-12
Ligand Pharmaceuticals USD 158.89M 149.17M 2025-09
MacroGenics USD 18.64M 55.4M 2025-09
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Veracyte USD 24.63M 1.52M 2025-12


Rigel Pharmaceuticals Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.